JPRN-UMIN000003957已完成未知
Evaluation of the efficacy of Sitagliptin plus peginterferon alfa 2b /ribavirin combination therapy in CHC patients with insulin resistance - ESPRIT study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Pregnant , possibly pregnant or lactating women 2) Patients with severe heart diseases 3) Chronic kidney failure or creatinine clearance of <=50 mL/min 4) Current or history of severe psychiatric disorder 5) Autoimmune hepatitis 6) Intolerance to sitagliptin 7) medication for diabetes
研究者
相似试验
招募中
3 期
Evaluation of the effectiveness of sitagliptin on metabolic factors and liver enzymesIRCT20191209045671N2Semnan University of Medical Sciences60
招募中
不适用
The evaluation of the efficacy of sitagliptin for NASH/NAFLD patients-a multicenter open-label studyJPRN-UMIN000005349Kyoto Prefectural University of Medicine, Department of Gastroenterology and Hepatology50
招募中
2 期
?Evaluation the effects of Sitagliptin administration in patients with COVID-19Pneumonia of COVID-19.COVID-19, virus identifiedU07.1IRCT20200420047147N1Shahid Beheshti University of Medical Sciences84
已完成
不适用
Efficacy of the combined therapy of sitagliptin and insulin in japanese type 2 diabetic patientstype 2 diabetesJPRN-UMIN000007075Fukuoka university, school of medicine, department of endocrinology and diabetes mellitus50
已完成
3 期
Comparison of the Efficacy of Sitagliptin with Pioglitazone on the Control of Diabetic PatientsDiabetes mellitus type 2.?E10-E14Diabetes mellitusIRCT201704246712N3Vice Chancellor for Research of Tabriz University of Medical Sciences90